XNAS 04 May, 2026 10:52 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Justin Van Fleet | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 100,000 | 230,435 | - | - | Stock Option (right to buy)* | |
| Carolyn Shelton | Sr. VP - Quality - Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 100,000 | 210,620 | - | - | Stock Option (right to buy)* | |
| Alan Kazden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 100,000 | 362,500 | - | - | Stock Option (right to buy)* | |
| David Owens | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 1,000,000 | 2,484,809 | - | - | Stock Option (right to buy)* | |
| Benjamin V. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy)* | |
| Mark White | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 1,000,000 | 2,387,024 | - | - | Stock Option (right to buy)* | |
| Alan Kazden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2025 | 36,459 | 119,590 | - | 0 | Common stock | |
| David Owens | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2025 | 36,459 | 191,252 | - | 0 | Common stock | |
| Benjamin V. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2025 | 36,459 | 377,095 | - | 0 | Common stock | |
| Carolyn Shelton | Sr. VP - Quality - Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2025 | 20,000 | 110,620 | - | - | Stock Option (right to buy) | |
| David Owens | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2025 | 100,000 | 1,484,809 | - | - | Stock Option (right to buy) | |
| David Owens | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2025 | 203,125 | 1,384,809 | - | - | Stock Option (right to buy) | |
| Marilyn Elson | Ten Percent Owner | 10 Sep 2025 | 23,150 | 112,850 | - | - | Common Stock Warrants | ||
| Marilyn Elson | Ten Percent Owner | 17 Jul 2025 | 30,000 | 316,000 | - | - | Stock Option (right to buy) | ||
| Marilyn Elson | Ten Percent Owner | 17 Jul 2025 | 30,000 | 346,000 | - | - | Stock Option (right to buy) | ||
| Marilyn Elson | Ten Percent Owner | 17 Jul 2025 | 150,000 | 286,000 | - | - | Stock Option (right to buy) | ||
| Marilyn Elson | Ten Percent Owner | 17 Jul 2025 | 30,000 | 406,000 | - | - | Stock Option (right to buy) | ||
| Marilyn Elson | Ten Percent Owner | 17 Jul 2025 | 30,000 | 436,000 | - | - | Stock Option (right to buy) | ||
| Marilyn Elson | Ten Percent Owner | 17 Jul 2025 | 30,000 | 376,000 | - | - | Stock Option (right to buy) | ||
| Carolyn Shelton | Sr. VP - Quality, Regulatory | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 12 Mar 2025 | 6,000 | 30,000 | - | 2.2 | 13,200 | Common Stock |
| David Owens | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 125,000 | 919,184 | - | - | Stock Option (right to buy) | |
| David Owens | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 654,363 | 794,184 | - | - | Stock Option (right to buy) | |
| David Owens | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 139,821 | 139,821 | - | - | Stock Option (right to buy) | |
| Mark White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 939,597 | 1,387,024 | - | - | Stock Option (right to buy) | |
| Mark White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 447,427 | 447,427 | - | - | Stock Option (right to buy) | |
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.98 per share. | 04 Feb 2025 | 1,000 | 154,793 | - | 3.0 | 2,980 | Common stock |
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.10 per share. | 04 Feb 2025 | 1,000 | 155,793 | - | 3.1 | 3,100 | Common stock |
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 28 Jan 2025 | 1,500 | 153,793 | - | 2.7 | 4,050 | Common stock |
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 13 Jan 2025 | 1,000 | 152,293 | - | 2.7 | 2,700 | Common stock |
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 13 Jan 2025 | 2,000 | 151,293 | - | 2.5 | 5,000 | Common stock |
| Alan Kazden | Director | 31 Dec 2024 | 262,500 | 262,500 | - | - | Stock Option (right to buy) | ||
| Carolyn Shelton | Senior VP | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 31 Dec 2024 | 24,000 | 24,000 | - | 0.9 | 20,400 | Common stock |
| Carolyn Shelton | Senior VP | 31 Dec 2024 | 90,620 | 90,620 | - | - | Stock Option (right to buy) | ||
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 31 Dec 2024 | 1,000 | 149,293 | - | 2.8 | 2,750 | Common stock |
| David Owens | Director, Chief Medical Officer | 31 Dec 2024 | 262,500 | 262,500 | - | - | Stock Option (right to buy) | ||
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.19 per share. | 28 Oct 2024 | 500 | 148,293 | - | 2.2 | 1,095 | Common stock |
| Marilyn Elson | Ten Percent Owner | 30 Sep 2024 | 700,000 | 1,535,244 | - | 0 | Common Stock | ||
| Benjamin V. Hue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 175,000 | 340,636 | - | 0 | Common stock | |
| Leslie Bernhard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 49,838 | 49,838 | - | 0 | Common stock | |
| Marilyn Elson | Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2024 | 700,000 | 1,535,244 | - | 0 | Common Stock | |
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 13 Aug 2024 | 1,000 | 147,793 | - | 1.0 | 950 | Common stock |
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 28 Jun 2024 | 1,000 | 146,793 | - | 1.8 | 1,750 | Common stock |
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 18 Jun 2024 | 1,619 | 145,793 | - | 0.7 | 1,149 | Common stock |
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.65 per share. | 10 Jun 2024 | 2,000 | 143,174 | - | 0.7 | 1,300 | Common stock |
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.62 per share. | 10 Jun 2024 | 1,000 | 144,174 | - | 0.6 | 620 | Common stock |
| Marilyn Elson | Ms. Elson serves as CFO, Ten Percent Owner | 28 Sep 2022 | 9,500 | 835,244 | - | 1.1 | 10,640 | Common Stock | |
| Marilyn Elson | Ten Percent Owner | 28 Sep 2022 | 36,000 | 136,000 | - | - | Common stock warrants | ||
| Marilyn Elson | Ms. Elson serves as CFO, Ten Percent Owner | 16 Sep 2022 | 36,000 | 825,744 | - | 4.2 | 149,400 | Common Stock | |
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 16 Sep 2022 | 2,500 | 141,174 | - | 4.2 | 10,375 | Common Stock |
| Rick J. Morad | Director | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 16 Sep 2022 | 2,500 | 108,341 | - | 4.2 | 10,375 | Common Stock |
| Marilyn Elson | Ms. Elson serves as CFO, Ten Percent Owner | 16 Sep 2022 | 100,000 | 100,000 | - | - | Common stock warrants | ||
| Alan Kazden | Director | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 16 Sep 2022 | 2,500 | 83,131 | - | 4.2 | 10,375 | Common Stock |
| Mark White | Director, President/CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Sep 2022 | 25,000 | 25,000 | - | - | Common stock warrants | |
| David Owens | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Sep 2022 | 2,500 | 2,500 | - | - | Common stock warrants | |
| Alan Kazden | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Sep 2022 | 2,500 | 2,500 | - | - | Common stock warrants | |
| Mark White | Director, President/CEO | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 15 Sep 2022 | 25,000 | 309,127 | - | 4.2 | 103,750 | Common Stock |
| Mark White | Director, President/CEO | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 15 Sep 2022 | 25,000 | 289,627 | - | 4.2 | 103,750 | Common Stock |